-
841
-
842
Photo-Oxygenation as a New Therapeutic Strategy for Neurodegenerative Proteinopathies by Enhancing the Clearance of Amyloid Proteins
Published 2022-06-01Subjects: Get full text
Article -
843
Administration of anti-ERMAP antibody ameliorates Alzheimer’s disease in mice
Published 2021-11-01Subjects: Get full text
Article -
844
The protective effect of early dietary fat consumption on Alzheimer's disease–related pathology and cognitive function in mice
Published 2021-01-01Subjects: Get full text
Article -
845
Aggregation Limiting Cell-Penetrating Peptides Derived from Protein Signal Sequences
Published 2023-02-01Subjects: “…amyloid beta…”
Get full text
Article -
846
Catechins as Tools to Understand the Molecular Basis of Neurodegeneration
Published 2020-08-01Subjects: Get full text
Article -
847
Advances in the development of new biomarkers for Alzheimer’s disease
Published 2022-04-01Subjects: Get full text
Article -
848
-
849
The Role of NMDA Receptors in Alzheimer’s Disease
Published 2019-02-01Subjects: Get full text
Article -
850
A systematic review for the development of Alzheimer’s disease in in vitro models: a focus on different inducing agents
Published 2023-12-01Subjects: Get full text
Article -
851
Acrolein adducts and responding autoantibodies correlate with metabolic disturbance in Alzheimer’s disease
Published 2023-06-01Subjects: Get full text
Article -
852
Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease
Published 2022-01-01Subjects: Get full text
Article -
853
Blood-Based Biomarkers for Predictive Diagnosis of Cognitive Impairment in a Pakistani Population
Published 2020-07-01Subjects: Get full text
Article -
854
Genistein effect on cognition in prodromal Alzheimer’s disease patients. The GENIAL clinical trial
Published 2022-11-01Subjects: Get full text
Article -
855
Release of frustration drives corneal amyloid disaggregation by brain chaperone
Published 2023Subjects: Get full text
Journal Article -
856
circBIRC6 contributes to the development of non-small cell lung cancer via regulating microRNA-217/amyloid beta precursor protein binding protein 2 axis
Published 2022-03-01“…Quantitative real-time polymerase chain reaction was conducted for assessing the levels of circBIRC6, amyloid beta precursor protein binding protein 2 (APPBP2) messenger RNA (mRNA), baculoviral IAP repeat containing 6 mRNA (BIRC6), and microRNA-217 (miR-217). …”
Get full text
Article -
857
Amyloid-beta induced CA1 pyramidal cell loss in young adult rats is alleviated by systemic treatment with FGL, a neural cell adhesion molecule-derived mimetic peptide.
Published 2013-01-01“…Increased levels of neurotoxic amyloid-beta in the brain are a prominent feature of Alzheimer's disease. …”
Get full text
Article -
858
-
859
Targeting alpha synuclein and amyloid beta by a multifunctional, brain-penetrant dopamine D2/D3 agonist D-520: Potential therapeutic application in Parkinson’s disease with dementia
Published 2019-12-01“…This is characterized by cortical and limbic alpha synuclein (α-syn) accumulation, and high levels of diffuse amyloid beta (Aβ) plaques in the striatum and neocortical areas. …”
Get full text
Article -
860
Methyltransferase-Like 3 Rescues the Amyloid-beta protein-Induced Reduction of Activity-Regulated Cytoskeleton Associated Protein Expression via YTHDF1-Dependent N6-Methyladenosine Modification
Published 2022-04-01“…There were five m6A modification sites of ARC mRNA that were predicted by the SRAMP database, and ARC mRNA was confirmed as the target gene of methyltransferase-like 3 (METTL3) by MeRIP. Amyloid-beta protein (Aβ) repressed the m6A modification. …”
Get full text
Article